Philip Murphy

1.1k total citations
54 papers, 533 citations indexed

About

Philip Murphy is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Philip Murphy has authored 54 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 17 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Philip Murphy's work include Multiple Myeloma Research and Treatments (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Philip Murphy is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Philip Murphy collaborates with scholars based in Ireland, United Kingdom and Italy. Philip Murphy's co-authors include John Quinn, J. R. O’Donnell, Siobhán Glavey, Najma N. Ahmed, H.T. Hassan, Daniel Freeman, Richard P. Bentall, Paul Hutton, Michael J. Stuart and Suzanne O’Rourke and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Philip Murphy

48 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Murphy Ireland	13	203	95	95	79	74	54	533
Inge M. Appel Netherlands	14	245 1.2×	96 1.0×	38 0.4×	39 0.5×	120 1.6×	27	800
L. Chen United States	13	112 0.6×	69 0.7×	269 2.8×	183 2.3×	77 1.0×	21	744
George Chen United States	10	240 1.2×	40 0.4×	51 0.5×	73 0.9×	167 2.3×	29	715
A Hartkamp Netherlands	14	89 0.4×	127 1.3×	238 2.5×	65 0.8×	87 1.2×	19	661
Ritva Peltomaa Finland	13	122 0.6×	47 0.5×	345 3.6×	35 0.4×	48 0.6×	27	571
Veerle Labarque Belgium	14	210 1.0×	85 0.9×	27 0.3×	48 0.6×	32 0.4×	54	516
H. C. M. Haanen Netherlands	10	203 1.0×	82 0.9×	534 5.6×	47 0.6×	72 1.0×	13	851
R. Confalonieri Italy	12	67 0.3×	100 1.1×	187 2.0×	87 1.1×	24 0.3×	21	727
Philip Connor United Kingdom	11	233 1.1×	59 0.6×	45 0.5×	37 0.5×	15 0.2×	24	545
Tatyana Ionova Russia	10	145 0.7×	54 0.6×	29 0.3×	54 0.7×	200 2.7×	90	469

Countries citing papers authored by Philip Murphy

Since Specialization

Citations

This map shows the geographic impact of Philip Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Murphy more than expected).

Fields of papers citing papers by Philip Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Murphy. The network helps show where Philip Murphy may publish in the future.

Co-authorship network of co-authors of Philip Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Murphy. A scholar is included among the top collaborators of Philip Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Murphy. Philip Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quinn, John, et al.. (2023). Genetic Abnormalities in Extramedullary Multiple Myeloma. International Journal of Molecular Sciences. 24(14). 11259–11259. 8 indexed citations

Swan, Dawn, Philip Murphy, Siobhán Glavey, & John Quinn. (2023). Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety. Cancers. 15(6). 1819–1819. 24 indexed citations

Swan, Dawn, Robert B. Henderson, John Quinn, et al.. (2022). CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment. Clinical Lymphoma Myeloma & Leukemia. 22(11). 847–852. 1 indexed citations

Glavey, Siobhán, et al.. (2019). Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma. Experimental Hematology and Oncology. 8(1). 4–4. 6 indexed citations

Langabeer, Stephen E., et al.. (2018). Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia. SHILAP Revista de lepidopterología. 2018. 1–4.

Murphy, Philip, Richard P. Bentall, Daniel Freeman, Suzanne O’Rourke, & Paul Hutton. (2018). The paranoia as defence model of persecutory delusions: a systematic review and meta-analysis. The Lancet Psychiatry. 5(11). 913–929. 50 indexed citations

Moore, Margaret, et al.. (2017). From a DOAC to Warfarin: Reasons Why Patients Switch. Blood. 130. 4910–4910.

Leleu, Xavier, Charalampia Kyriakou, Isabelle Vande Broek, et al.. (2017). Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment. Blood Cancer Journal. 7(3). e543–e543. 11 indexed citations

Murphy, Philip, et al.. (2012). Queen Elizabeth II should be the final Head of the Commonwealth. SAS-Space (University of London). 1 indexed citations

10.

Sivakumaran, M., et al.. (2008). Visual hallucinations following treatment with vincristine. Clinical & Laboratory Haematology. 16(4). 355–357. 1 indexed citations

11.

Kelly, Kevin R. & Philip Murphy. (2008). Aplastic anaemia preceding acute lymphoblastic leukaemia in an adult with isolated deletion of chromosome 9q. Leukemia Research. 32(12). 1936–1938. 8 indexed citations

12.

Swords, Ronan, et al.. (2005). CML clonal evolution with resistance to single agent imatinib therapy. Clinical & Laboratory Haematology. 27(5). 347–349. 9 indexed citations

13.

Sutcliffe, Robert P., Donal Maguire, Philip Murphy, et al.. (2005). Detection and Clinical Significance of Bone Marrow Micrometastases in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Transplantation. 80(1). 88–94. 11 indexed citations

14.

Johnston, Simon D., S A McMillan, John S. A. Collins, et al.. (2003). A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. European Journal of Gastroenterology & Hepatology. 15(9). 1001–1004. 25 indexed citations

15.

Murphy, Philip, Najma N. Ahmed, & H.T. Hassan. (2002). Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera. Leukemia Research. 26(11). 1007–1010. 28 indexed citations

16.

Murphy, Philip & Nathan O’Connor. (2001). Low risk of central venous thrombosis with nontunnelled central venous catheters. Clinical & Laboratory Haematology. 23(3). 187–188. 2 indexed citations

17.

Murphy, Philip, et al.. (1998). Audit of patients on oral anticoagulants with International normalized ratios of eight or above. Clinical & Laboratory Haematology. 20(4). 253–257. 5 indexed citations

18.

Konje, Justin C., et al.. (1994). Severe factor X deficiency and successful pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 101(10). 910–911. 19 indexed citations

19.

Murphy, Philip & J. R. O’Donnell. (1990). B19 parvovirus infection causing aplastic crisis in 3 out of 5 family members with hereditary spherocytosis. Irish Journal of Medical Science (1971 -). 159(6). 182–184. 5 indexed citations

20.

Murphy, Philip, et al.. (1990). ALFA‐INTERFERON IN A CASE OF HYPEREOSINOPHILIC SYNDROME. British Journal of Haematology. 75(4). 619–620. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact